Advanced Enzyme Technologies Approves Buyback of Equity Shares Up To 10% Of Capital
Advanced Enzyme Technologies Limited has approved the buyback of its equity shares, with the board resolution indicating a maximum aggregate purchase size not exceeding ₹ 697,000,000. The decision was ratified by the Board of Directors during a meeting held on August 08, 2026.The company approved the buyback of fully paid-up equity shares, which have a face value of ₹ 2 per share. The purchase will be conducted through an open market route via Stock Exchanges (BSE and NSE), with payment made in cash only.
Key parameters established under the resolution include:
- Maximum Buyback Price: Not exceeding ₹ 500 per Equity Share.
- Maximum Buyback Size: Aggregate amount not exceeding ₹ 697,000,000.
- Permissible Limit: The buyback is within the statutory limit of up to 10% of the aggregate of the fully paid-up equity share capital and free reserves of the company, based on audited standalone financial statements as of March 31, 2026.
The indicative maximum number of Equity Shares that could be bought back is 1,394,000 shares, which represents 1.24% of the total paid-up Equity Shares of the company as of August 08, 2026. This amount corresponds to 9.99% of the aggregate of the total paid-up equity share capital and free reserves based on the last audited standalone financial statements.
Financial Parameters of the Buyback Offer
| Metric | Value | Details |
|---|---|---|
| Maximum Buyback Price | ₹ 500 per Equity Share | Determined by various market indicators (see note). |
| Maximum Buyback Size | ₹ 697,000,000 | Corresponds to up to 10% of paid-up capital and free reserves. |
| Indicative Max Shares | 1,394,000 shares | Represents 1.24% of total paid-up Equity Shares. |
| Minimum Buyback Size | ₹ 522,750,000 | A minimum size must be utilized during the offer period. |
The Maximum Buyback Price was set after considering several financial metrics relating to the company's standing and market trends. The price represents a premium over the volume weighted average market price (VWAP) for two weeks, one month, or three months prior to the Board meeting, as well as a premium over the closing market price on August 01, 2026. On this date, the closing market prices were ₹ 324.40 on BSE and ₹ 324.35 on NSE.
Buyback Implementation Details
The company has also mandated specific parameters for the buyback process:- Utilization Commitment: At least 75% of the Minimum Buyback Size (₹ 522,750,000) must be utilized.
- Initial Offer Target: A minimum of 40% of the Buyback Size, equating to ₹ 278,800,000, must be utilized within the initial half of the Offer Period.
- Offer Period: The buyback offer will open within four working days from the public announcement and close either sixty six working days from the opening date or upon completing the Maximum Buyback Size, whichever is earlier.
The board also appointed various parties to manage the process, including Emkay Global Financial Services Limited as the Merchant Banker/Manager, Mr Sanjay Basantani as the Compliance Officer, and MUFG Intime India Private Limited as the Registrar for the Buyback transaction.
ADVENZYMES Stock Price Movement
Advanced Enzyme Technologies Limited closed today after gaining ₹3.50, pushing shares up 1.19% to settle at ₹298.30. The stock traded within a daily range of ₹291.05 to ₹299.55, with 366,896 shares exchanged during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: